#MultScler
🎥 Marcello Moccia comments on the association between neurofilament and invisible symptoms of #MultipleSclerosis, including cognitive dysfunction, depression, and fatigue:

👉 buff.ly/eW8A7YG 👈

#MS #MultScler #Neuroscience #Neurology #EAN2025 #MedSky
October 2, 2025 at 2:04 PM
In an interview from #EAN2025, Celia Oreja-Guevara discusses the importance of early detection of silent progression in patients with #MS.

Click here to watch:
👉 buff.ly/YhEAYwv 👈

#MultScler #MultipleSclerosis #Neurology #MedSky
September 17, 2025 at 1:03 PM
Watch our interview with Marcello Moccia to hear about a study comparing different age-derived cut-offs for plasma neurofilament light chain in #MultipleSclerosis.

Click here:
👉 buff.ly/yaa0Q9L

#MS #MultScler #Neuroscience #Neurology #EAN2025
buff.ly
September 5, 2025 at 11:01 AM
What is the impact of the new McDonald diagnostic criteria for #MultipleSclerosis? 🧠

Marcello Moccia discussed this in a recent interview:

🎥 buff.ly/9DcoI2r

#MS #MultScler #Neuroscience #Neurology #EAN2025 #MedSky
August 19, 2025 at 1:04 PM
Want to hear the details of a study investigating soluble factors that contribute to broad rim lesion formation in #MultipleSclerosis?

Then make sure to check out our interview with Joost Smolders from #EAN2025:

🎥 buff.ly/P7pXCa9

#CTSM #MS #MultScler #Neurology #MedSky
August 13, 2025 at 3:43 PM
Want to find out about the recent revision of the McDonald criteria for the diagnosis of #MultipleSclerosis?🧠

Click here to watch our insightful interview with Marcello Moccia:

👉 buff.ly/1E9VzZJ

#MS #MultScler #Neuroscience #Neurology #EAN2025 @ean.org #MedSky
August 7, 2025 at 2:04 PM
The EnvIMS study was a multinational case-control study investigating childhood infections and their impact on #MultipleSclerosis onset in adults.

Caterina Ferri shares the findings in an interview from #EAN2025:

🎥 buff.ly/RRgMxfp

#MS #MultScler #CTSM #Neurology #MedSky
July 31, 2025 at 11:01 AM
In an interview from #EAN2025, Celia Oreja-Guevara comments on the inclusion of the central vein sign in the McDonald diagnostic criteria for #MultipleSclerosis to allow for its differentiation from similar diseases:

👉 buff.ly/yR8xfQv

#MultScler #Neurology #Neuroscience #MedSky @ean.org
July 29, 2025 at 12:02 PM
Want to hear as Celia Oreja-Guevara shares her highlights in #MultipleSclerosis from #EAN2025? 🧠

Make sure to check out our interview with her by clicking here:

👉 buff.ly/4YnGgfV 👈

#MS #MultScler #MedSky #Neurology @ean.org
July 8, 2025 at 1:04 PM
As it's #WorldMSDay, why not listen to our podcast with leading experts who provide insight into the recent revision of the McDonald diagnostic criteria for #MultipleSclerosis?🧠

Check it out here:
🎧 buff.ly/5R4rqcU

#MS #MultScler #Neurology #MSAwareness #MedSky
May 30, 2025 at 3:06 PM
#AANAM | Enric Monreal discusses the role of biomarkers in transitioning from evidence-based medicine to personalized medicine in #MultipleSclerosis:

🎥 buff.ly/cCDoeEs

#MedSky #MS #MultScler #Neurology #Neuroscience
May 16, 2025 at 4:05 PM
#MSWeek | Enric Monreal presents findings of a study investigating the predictive value of the combination of CSF and serum biomarkers at disease onset in #MultipleSclerosis. 🧠🩸

Watch here:
🎥 buff.ly/UWJgWR8

#MS #MultScler #Neurology #AANAM
April 30, 2025 at 2:05 PM
At the European CAR T-cell meeting, we spoke with Johanna Richter to hear about the preliminary data from a single-center experience with CD19-directed CAR-T in patients with #MultipleSclerosis.

Watch here:
👉 buff.ly/Xyuvgwu

#MS #MultScler #CART25 #Neurology
March 21, 2025 at 11:16 AM
There is a need to enhance the use of advanced MRI in MS diagnosis and monitoring.🧠

Hear more about this in our interview with Dr Serena Borrelli:

🎥 https://buff.ly/3CD7dlY

#MS #MultScler #MultipleSclerosis #EAN2024 #Neuroscience
February 12, 2025 at 10:02 AM
🎥 Dr Serena Borrelli discusses a proposed approach for simplifying the assessment of central vein sign positivity in clinical practice.

Click here to watch:
👉 https://buff.ly/40nXHuQ 👈

#MS #MultScler #MultipleSclerosis #EAN2024 #Neuroscience
January 30, 2025 at 2:00 PM
#ECTRIMS2024 | Emilio Portaccio outlines the two ways disability accrual occurs in #MultipleSclerosis – relapse-associated worsening (RAW) & progression independent from relapse activity (PIRA).

Click here:
👉 https://buff.ly/4gZeUl3

#MultScler #MS #Neurology #Neuroscience
January 6, 2025 at 1:00 PM
Have you listened to our newest podcast yet?🤔🎧

Don't miss out on this fantastic episode if you want to gain insight into the latest updates to the McDonald diagnostic criteria for #MultipleSclerosis.🧠

Listen here:
👉 https://buff.ly/41c1qOe 👈

#MS #MultScler
January 1, 2025 at 4:00 PM
The central vein sign (CVS) is a central linear hypointensity within lesions on T2*-weighted imaging.

Celia Oreja-Guevara discusses its clinical value in the diagnosis of #MultipleSclerosis:

👉 https://buff.ly/4iAq15x 👈

#MS #MultScler #Neuroscience #Neurology
December 27, 2024 at 2:00 PM
What are the similarities between chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and #MultipleSclerosis?🤔

Watch our interview with Alicja Kalinowska to find out:
👉 https://buff.ly/49HS5jb

#MS #MultScler
December 23, 2024 at 4:00 PM
Earlier this year, we interviewed Maya Zeineddine to hear about the differences between treatment with natalizumab and anti-CD20 monoclonal antibodies in #MultipleSclerosis.

Watch here:
👉 https://buff.ly/3ZAA42V

#MS #MultScler #ECTRIMS2024 #Neuroscience
Natalizumab versus anti-CD20 monoclonal antibodies in the treatment of MS - VJNeurology
Maya Zeineddine, PharmD, Lebanese American University, Byblos, Lebanon, discusses the differences between treatment with natalizumab and anti-CD20 monoclonal antibodies in...
buff.ly
December 13, 2024 at 2:00 PM
#CARTCell therapy has revolutionized the treatment of hematological malignancies and is now being considered as a potential treatment for neurological conditions, including #MultipleSclerosis!

Learn more from Krish Patel here:
👉https://buff.ly/3Z7S7MG

#ECTRIMS2024 #MS #MultScler
Investigating CAR T-cell therapy in the treatment of MS - VJNeurology
Krish Patel, MD, Swedish Cancer Institute, Seattle, WA, discusses the potential use of chimeric antigen receptor (CAR) T-cell therapy to...
buff.ly
December 9, 2024 at 2:00 PM
It was a pleasure to interview Anneke Van der Walt, who provided insight into evobrutinib and other BTK inhibitors for the treatment of #MultipleSclerosis.

Click here to watch:
👉 https://buff.ly/3Z8JMbw

#ECTRIMS2024 #MultScler #MS #Neuroscience #Neurology
Investigating evobrutinib and other BTK inhibitors for the treatment of MS - VJNeurology
Anneke Van der Walt, PhD, Monash University, Melbourne, Australia, discusses the use of evobrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor,...
buff.ly
December 7, 2024 at 5:00 PM
In an interview from #ECTRIMS2024, Helen Tremlett introduces the concept of a prodromal phase in #MultipleSclerosis and comments on how it has been neglected.

Watch it here:
👉 https://buff.ly/3B1PiVt

#MultScler #MS #Neuroscience #Neurology
December 5, 2024 at 12:00 PM
Our new podcast is live! 🎧

Hear about the latest updates to the McDonald diagnostic criteria for #MultipleSclerosis from leading experts in the field. 🧠

Click here to listen:
👉 https://buff.ly/41c1qOe 👈

#MS #MultScler #Neurology #Neuroscience
December 4, 2024 at 2:00 PM